BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2839223)

  • 21. Parvovirus b19 infection in HIV patient with pure red cell aplasia.
    Sanphasitvong W; Poovorawan K; Boonsuk P; Assanasen T; Na Nakorn T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1216-20. PubMed ID: 16438148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.
    Frickhofen N; Abkowitz JL; Safford M; Berry JM; Antunez-de-Mayolo J; Astrow A; Cohen R; Halperin I; King L; Mintzer D
    Ann Intern Med; 1990 Dec; 113(12):926-33. PubMed ID: 2173460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.
    Zhang M; Zhong X; Zhang W; Xu J; Zhang M; Shen Y; Wang W; Zheng S
    Int J Clin Pract Suppl; 2015 May; (183):29-34. PubMed ID: 26177162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pure red cell aplasia in a lung transplant patient].
    Acosta O; Tarín F; León A; Moreno A; Bello MD; Pérez A
    Arch Bronconeumol; 2002 Mar; 38(3):147-9. PubMed ID: 11900693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comment on "Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy" by Intalapaporn et al.
    Koduri PR
    J Infect; 2007 Jul; 55(1):90-1. PubMed ID: 17083979
    [No Abstract]   [Full Text] [Related]  

  • 26. Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1. Recovery with alpha-interferon therapy.
    Martins A; Costa A; Oliveira MJ; Rodrigues M; Ribeiro AP; Silvestre F; Reis A
    Sangre (Barc); 1998 Feb; 43(1):67-9. PubMed ID: 9577184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.
    Kurtzman G; Frickhofen N; Kimball J; Jenkins DW; Nienhuis AW; Young NS
    N Engl J Med; 1989 Aug; 321(8):519-23. PubMed ID: 2548098
    [No Abstract]   [Full Text] [Related]  

  • 28. Parvovirus infection and hemolytic anemia.
    Kunimi M; Ishikawa K; Tsutsumi H; Hirai M; Kumakawa T; Mori M
    Am J Hematol; 1994 Jun; 46(2):159-60. PubMed ID: 8172189
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pure red cell aplasia due to parvovirus B19 occurred in a patient with liver cirrhosis C and hepatocellular carcinoma].
    Umekawa Y; Nishishita C; Okamoto E; Okuyama T; Rai T; Ikeda S
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):57-61. PubMed ID: 12601930
    [No Abstract]   [Full Text] [Related]  

  • 30. Human parvovirus B19-induced transient red cell aplasia in a patient with vitamin B12 deficiency.
    Hashimoto N; Ueda T; Hiraiwa S; Tajiri T; Yokoyama K
    Br J Haematol; 2016 Jun; 173(5):661. PubMed ID: 26970225
    [No Abstract]   [Full Text] [Related]  

  • 31. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
    Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
    Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis.
    Viallard JF; Parrens M; Hermine O; Boiron JM; Lafon ME; Marit G; Reiffers J; Pellegrin JL
    Clin Infect Dis; 2003 Jan; 36(2):229-33. PubMed ID: 12522758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient erythroblastopenia of childhood due to human parvovirus B19 infection.
    Wodzinski MA; Lilleyman JS
    Br J Haematol; 1989 Sep; 73(1):127-8. PubMed ID: 2553096
    [No Abstract]   [Full Text] [Related]  

  • 34. Parvovirus B19 co-infection with falciparum malaria: a cause of severe anemia.
    Gupta R; Singh T
    Haematologica; 2005 Dec; 90(12 Suppl):ECR41. PubMed ID: 16464756
    [No Abstract]   [Full Text] [Related]  

  • 35. Parvovirus B19 infection associated with reticulocytopenia and chronic autoimmune hemolytic anemia.
    Smith MA; Shah NS; Lobel JS
    Am J Pediatr Hematol Oncol; 1989; 11(2):167-9. PubMed ID: 2546464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute eryhtroblastopenia and polyarthralgia associated with human parvovirus infection (PSH-B19)].
    De Caluwé JP; Morinet F; Pérol Y; Burtonboy G
    Acta Clin Belg; 1987; 42(6):437-44. PubMed ID: 2829485
    [No Abstract]   [Full Text] [Related]  

  • 37. Aplastic crisis associated with parvovirus B19 in an adult with hereditary spherocytosis.
    Beland SS; Daniel GK; Menard JC; Miller NM
    J Ark Med Soc; 1997 Sep; 94(4):163-4. PubMed ID: 9308316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Familial transient red cell aplasia from parvovirus B-19 infection].
    Salvini F; Tonella M; Carpani G; Scaglioni S; Zuccotti GV
    Pediatr Med Chir; 2002; 24(4):306-7. PubMed ID: 12197091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia.
    Ito S; Oyake T; Uchiyama T; Sugawara T; Murai K; Ishida Y
    Int J Hematol; 2004 Oct; 80(3):250-3. PubMed ID: 15540900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection.
    Griffin TC; Squires JE; Timmons CF; Buchanan GR
    J Pediatr; 1991 Jun; 118(6):899-901. PubMed ID: 1645771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.